Haw Par Corp Ltd: A Strong and Steady Uptrend

Haw Par Corporation Limited has been identified as a top pick for investors due to its robust and consistent uptrend. The company, listed on the Singapore Exchange, operates in the healthcare and leisure sectors, with significant contributions from its globally recognized brand, Tiger Balm. The stock’s technical indicators signal bullish momentum, making it a compelling choice for growth-focused investors.

Key Technical Highlights:

• Current price: S\$11.60
• Entry prices: S\$11.60, S\$11.00, S\$10.81
• Support levels: S\$11.49, S\$11.00
• Stop-loss: S\$10.45
• Resistance levels: S\$12.61, S\$15.92
• Target prices:
  • Target 1: S\$12.10
  • Target 2: S\$12.88
  • Target 3: S\$14.00
  • Target 4: S\$15.11

Technical Analysis Deep Dive:

Haw Par’s stock has demonstrated a strong uptrend since October 2022, with a secondary uptrend evident since August 2024. The price action has broken above a pennant, indicating further upward momentum. The stock is trading above all Ichimoku indicators, while the MACD/signal line remains elevated above the zero line, reflecting positive momentum. Additionally, the stochastic oscillator is rising steadily, and the 23-period Rate of Change (ROC) has moved above the zero line, signaling bullish strength. The directional movement index confirms strong bullish sentiment, and trading volume remains above the 20-period average, indicating sustained investor interest.

Analyst Recommendation:

Rating: Add

The analyst maintains a positive outlook, supported by the company’s strong technical indicators and growth potential.

Li Auto Inc: Technical Buy Opportunity

Li Auto Inc, listed on the Hong Kong Exchange (2015), presents a technical buy opportunity for investors looking to capitalize on its upward price trajectory. The company offers scalable entry points and promising upside potential across multiple target price levels.

Key Technical Highlights:

• Entry prices: HK\$103.20, HK\$94.10, HK\$84.80
• Stop-loss: HK\$82.14
• Target prices:
  • Target 1: HK\$130.80
  • Target 2: HK\$154.54
  • Target 3: HK\$176.30
  • Target 4: HK\$200.00

Outlook:

Li Auto’s stock demonstrates significant technical strength, with clear entry points and well-defined stop-loss levels. The multiple target price levels indicate substantial room for growth, offering diversified opportunities for profit-taking at different stages.

Analyst Recommendation:

Rating: Technical Buy

The recommendation underscores confidence in the stock’s upward momentum and its potential to deliver strong returns.

Parkway Life REIT: Healthy Growth Outlook

Parkway Life REIT, a defensive income-generating asset in the Singapore market, offers a stable and healthy growth trajectory. Its 2H24/FY24 DPU stood at 7.38/14.92 Singapore cents, aligning closely with projections and reflecting its resilience and steady performance.

Key Highlights:

• 2H24/FY24 DPU: 7.38/14.92 Singapore cents
• Forecast alignment: 49.3%/99.7% of FY24F forecast
• Target price: S\$4.91, based on a Discounted Dividend Model (DDM)

Growth Drivers:

The company’s robust FY25F DPU growth is driven by its defensive Singapore income structure and full-year contributions from its European properties. These factors position Parkway Life REIT as a reliable investment for income-focused portfolios.

Analyst Recommendation:

Rating: Add

The recommendation reflects confidence in the REIT’s stability and its ability to deliver consistent returns.

Other Notable Mentions

China Strategy: Year of Revaluation

The report discusses the implications of DeepSeek, suggesting a revaluation of strategies tailored for China’s evolving market dynamics. Investors are encouraged to stay vigilant for opportunities in rapidly changing conditions.

Siloam International Hospitals: Resolving Private Insurance Issues

In the Indonesian market, Siloam International Hospitals is expected to resolve private insurance issues soon, paving the way for improved operational performance and financial health.

Bangchak Corporation: Rising Operational Headwinds

Bangchak Corporation in Thailand faces rising operational challenges. Investors are advised to consider the potential implications of these headwinds on the company’s long-term growth.